1st level
|
2nd level
|
3rd level
|
4th level
|
5th level
|
Contents
|
A
|
|
|
|
|
Alimentary tract and metabolism
|
|
A01
|
|
|
|
Stomatological preparations
|
|
|
A01A
|
|
|
Stomatological preparations
|
|
|
|
A01AA
|
|
Caries prophylactic agents
|
|
|
|
|
A01AA01
|
Sodium fluoride
|
|
|
|
|
A01AA02
|
Sodium monofluorophosphate
|
|
|
|
|
A01AA03
|
Olaflur
|
|
|
|
|
A01AA04
|
Stannous fluoride
|
|
|
|
|
A01AA30
|
Combinations
|
|
|
|
|
A01AA51
|
Sodium fluoride, combinations
|
|
|
|
A01AB
|
|
Anti-infectives and antiseptics for local oral treatment
|
|
|
|
|
A01AB02
|
Hydrogen peroxide
|
|
|
|
|
A01AB03
|
Chlorhexidine
|
|
|
|
|
A01AB04
|
Amphotericin B
|
|
|
|
|
A01AB05
|
Polynoxylin
|
|
|
|
|
A01AB06
|
Domiphen
|
|
|
|
|
A01AB07
|
Oxyquinoline
|
|
|
|
|
A01AB08
|
Neomycin
|
|
|
|
|
A01AB09
|
Miconazole
|
|
|
|
|
A01AB10
|
Natamycin
|
|
|
|
|
A01AB11
|
Various
|
|
|
|
|
A01AB12
|
Hexetidine
|
|
|
|
|
A01AB13
|
Tetracycline
|
|
|
|
|
A01AB14
|
Benzoxonium chloride
|
|
|
|
|
A01AB15
|
Tibezonium iodide
|
|
|
|
|
A01AB16
|
Mepartricin
|
|
|
|
|
A01AB17
|
Metronidazole
|
|
|
|
|
A01AB18
|
Clotrimazole
|
|
|
|
|
A01AB19
|
Sodium perborate
|
|
|
|
|
A01AB21
|
Chlortetracycline
|
|
|
|
|
A01AB22
|
Doxycycline
|
|
|
|
|
A01AB23
|
Minocycline
|
|
|
|
A01AC
|
|
Corticosteroids for local oral treatment
|
|
|
|
|
A01AC01
|
Triamcinolone
|
|
|
|
|
A01AC02
|
Dexamethasone
|
|
|
|
|
A01AC03
|
Hydrocortisone
|
|
|
|
|
A01AC54
|
Prednisolone, combinations
|
|
|
|
A01AD
|
|
Other agents for local oral treatment
|
|
|
|
|
A01AD01
|
Epinephrine
|
|
|
|
|
A01AD02
|
Benzydamine
|
|
|
|
|
A01AD05
|
Acetylsalicylic acid
|
|
|
|
|
A01AD06
|
Adrenalone
|
|
|
|
|
A01AD07
|
Amlexanox
|
|
|
|
|
A01AD08
|
Becaplermin
|
|
|
|
|
A01AD11
|
Various
|
|
A02
|
|
|
|
Drugs for acid related disorders
|
|
|
A02A
|
|
|
Antacids
|
|
|
|
A02AA
|
|
Magnesium compounds
|
|
|
|
|
A02AA01
|
Magnesium carbonate
|
|
|
|
|
A02AA02
|
Magnesium oxide
|
|
|
|
|
A02AA03
|
Magnesium peroxide
|
|
|
|
|
A02AA04
|
Magnesium hydroxide
|
|
|
|
|
A02AA05
|
Magnesium silicate
|
|
|
|
|
A02AA10
|
Combinations
|
|
|
|
A02AB
|
|
Aluminium compounds
|
|
|
|
|
A02AB01
|
Aluminium hydroxide
|
|
|
|
|
A02AB02
|
Algeldrate
|
|
|
|
|
A02AB03
|
Aluminium phosphate
|
|
|
|
|
A02AB04
|
Dihydroxialumini sodium carbonate
|
|
|
|
|
A02AB05
|
Aluminium acetoacetate
|
|
|
|
|
A02AB06
|
Aloglutamol
|
|
|
|
|
A02AB07
|
Aluminium glycinate
|
|
|
|
|
A02AB10
|
Combinations
|
|
|
|
A02AC
|
|
Calcium compounds
|
|
|
|
|
A02AC01
|
Calcium carbonate
|
|
|
|
|
A02AC02
|
Calcium silicate
|
|
|
|
|
A02AC10
|
Combinations
|
|
|
|
A02AD
|
|
Combinations and complexes of aluminium, calcium and magnesium compounds
|
|
|
|
|
A02AD01
|
Ordinary salt combinations
|
|
|
|
|
A02AD02
|
Magaldrate
|
|
|
|
|
A02AD03
|
Almagate
|
|
|
|
|
A02AD04
|
Hydrotalcite
|
|
|
|
|
A02AD05
|
Almasilate
|
|
|
|
A02AF
|
|
Antacids with antiflatulents
|
|
|
|
|
A02AF01
|
Magaldrate and antiflatulents
|
|
|
|
|
A02AF02
|
Ordinary salt combinations and antiflatulents
|
|
|
|
A02AG
|
|
Antacids with antispasmodics
|
|
|
|
|
|
Empty
|
|
|
|
A02AH
|
|
Antacids with sodium bicarbonate
|
|
|
|
|
|
Empty
|
|
|
|
A02AX
|
|
Antacids, other combinations
|
|
|
|
|
|
Empty
|
|
|
A02B
|
|
|
Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
A02BA
|
|
H2-receptor antagonists
|
|
|
|
|
A02BA01
|
Cimetidine
|
|
|
|
|
A02BA02
|
Ranitidine
|
|
|
|
|
A02BA03
|
Famotidine
|
|
|
|
|
A02BA04
|
Nizatidine
|
|
|
|
|
A02BA05
|
Niperotidine
|
|
|
|
|
A02BA06
|
Roxatidine
|
|
|
|
|
A02BA07
|
Ranitidine bismuth citrate
|
|
|
|
|
A02BA08
|
Lafutidine
|
|
|
|
|
A02BA51
|
Cimetidine, combinations
|
|
|
|
|
A02BA53
|
Famotidine, combinations
|
|
|
|
A02BB
|
|
Prostaglandins
|
|
|
|
|
A02BB01
|
Misoprostol
|
|
|
|
|
A02BB02
|
Enprostil
|
|
|
|
A02BC
|
|
Proton pump inhibitors
|
|
|
|
|
A02BC01
|
Omeprazole
|
|
|
|
|
A02BC02
|
Pantoprazole
|
|
|
|
|
A02BC03
|
Lansoprazole
|
|
|
|
|
A02BC04
|
Rabeprazole
|
|
|
|
|
A02BC05
|
Esomeprazole
|
|
|
|
|
A02BC06
|
Dexlansoprazole
|
|
|
|
A02BD
|
|
Combinations for eradication of Helicobacter pylori
|
|
|
|
|
A02BD01
|
Omeprazole, amoxicillin and metronidazole
|
|
|
|
|
A02BD02
|
Lansoprazole, tetracycline and metronidazole
|
|
|
|
|
A02BD03
|
Lansoprazole, amoxicillin and metronidazole
|
|
|
|
|
A02BD04
|
Pantoprazole, amoxicillin and clarithromycin
|
|
|
|
|
A02BD05
|
Omeprazole, amoxicillin and clarithromycin
|
|
|
|
|
A02BD06
|
Esomeprazole, amoxicillin and clarithromycin
|
|
|
|
|
A02BD07
|
Lansoprazole, amoxicillin and clarithromycin
|
|
|
|
|
A02BD08
|
Bismuth subcitrate, tetracycline and metronidazole
|
|
|
|
A02BX
|
|
Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
|
|
|
|
|
A02BX01
|
Carbenoxolone
|
|
|
|
|
A02BX02
|
Sucralfate
|
|
|
|
|
A02BX03
|
Pirenzepine
|
|
|
|
|
A02BX04
|
Methiosulfonium chloride
|
|
|
|
|
A02BX05
|
Bismuth subcitrate
|
|
|
|
|
A02BX06
|
Proglumide
|
|
|
|
|
A02BX07
|
Gefarnate
|
|
|
|
|
A02BX08
|
Sulglicotide
|
|
|
|
|
A02BX09
|
Acetoxolone
|
|
|
|
|
A02BX10
|
Zolimidine
|
|
|
|
|
A02BX11
|
Troxipide
|
|
|
|
|
A02BX12
|
Bismuth subnitrate
|
|
|
|
|
A02BX13
|
Alginic acid
|
|
|
|
|
A02BX51
|
Carbenoxolone, combinations excluding psycholeptics
|
|
|
|
|
A02BX71
|
Carbenoxolone, combinations with psycholeptics
|
|
|
|
|
A02BX77
|
Gefarnate, combinations with psycholeptics
|
|
|
A02X
|
|
|
Other drugs for acid related disorders
|
|
|
|
|
|
Empty
|
|
A03
|
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
A03A
|
|
|
Drugs for functional gastrointestinal disorders
|
|
|
|
A03AA
|
|
Synthetic anticholinergics, esters with tertiary amino group
|
|
|
|
|
A03AA01
|
Oxyphencyclimine
|
|
|
|
|
A03AA03
|
Camylofin
|
|
|
|
|
A03AA04
|
Mebeverine
|
|
|
|
|
A03AA05
|
Trimebutine
|
|
|
|
|
A03AA06
|
Rociverine
|
|
|
|
|
A03AA07
|
Dicycloverine
|
|
|
|
|
A03AA08
|
Dihexyverine
|
|
|
|
|
A03AA09
|
Difemerine
|
|
|
|
|
A03AA30
|
Piperidolate
|
|
|
|
A03AB
|
|
Synthetic anticholinergics, quaternary ammonium compounds
|
|
|
|
|
A03AB01
|
Benzilone
|
|
|
|
|
A03AB02
|
Glycopyrronium
|
|
|
|
|
A03AB03
|
Oxyphenonium
|
|
|
|
|
A03AB04
|
Penthienate
|
|
|
|
|
A03AB05
|
Propantheline
|
|
|
|
|
A03AB06
|
Otilonium bromide
|
|
|
|
|
A03AB07
|
Methantheline
|
|
|
|
|
A03AB08
|
Tridihexethyl
|
|
|
|
|
A03AB09
|
Isopropamide
|
|
|
|
|
A03AB10
|
Hexocyclium
|
|
|
|
|
A03AB11
|
Poldine
|
|
|
|
|
A03AB12
|
Mepenzolate
|
|
|
|
|
A03AB13
|
Bevonium
|
|
|
|
|
A03AB14
|
Pipenzolate
|
|
|
|
|
A03AB15
|
Diphemanil
|
|
|
|
|
A03AB16
|
(2-benzhydryloxyethyl)diethyl-methylammonium iodide
|
|
|
|
|
A03AB17
|
Tiemonium iodide
|
|
|
|
|
A03AB18
|
Prifinium bromide
|
|
|
|
|
A03AB19
|
Timepidium bromide
|
|
|
|
|
A03AB21
|
Fenpiverinium
|
|
|
|
|
A03AB53
|
Oxyphenonium, combinations
|
|
|
|
A03AC
|
|
Synthetic antispasmodics, amides with tertiary amines
|
|
|
|
|
A03AC02
|
Dimethylaminopropionylphenothiazine
|
|
|
|
|
A03AC04
|
Nicofetamide
|
|
|
|
|
A03AC05
|
Tiropramide
|
|
|
|
A03AD
|
|
Papaverine and derivatives
|
|
|
|
|
A03AD01
|
Papaverine
|
|
|
|
|
A03AD02
|
Drotaverine
|
|
|
|
|
A03AD30
|
Moxaverine
|
|
|
|
A03AE
|
|
Serotonin receptor antagonists
|
|
|
|
|
A03AE01
|
Alosetron
|
|
|
|
|
A03AE03
|
Cilansetron
|
|
|
|
A03AX
|
|
Other drugs for functional gastrointestinal disorders
|
|
|
|
|
A03AX01
|
Fenpiprane
|
|
|
|
|
A03AX02
|
Diisopromine
|
|
|
|
|
A03AX03
|
Chlorbenzoxamine
|
|
|
|
|
A03AX04
|
Pinaverium
|
|
|
|
|
A03AX05
|
Fenoverine
|
|
|
|
|
A03AX06
|
Idanpramine
|
|
|
|
|
A03AX07
|
Proxazole
|
|
|
|
|
A03AX08
|
Alverine
|
|
|
|
|
A03AX09
|
Trepibutone
|
|
|
|
|
A03AX10
|
Isometheptene
|
|
|
|
|
A03AX11
|
Caroverine
|
|
|
|
|
A03AX12
|
Phloroglucinol
|
|
|
|
|
A03AX13
|
Silicones
|
|
|
|
|
A03AX30
|
Trimethyldiphenylpropylamine
|
|
|
|
|
A03AX58
|
Alverine, combinations
|
|
|
A03B
|
|
|
Belladonna and derivatives, plain
|
|
|
|
A03BA
|
|
Belladonna alkaloids, tertiary amines
|
|
|
|
|
A03BA01
|
Atropine
|
|
|
|
|
A03BA03
|
Hyoscyamine
|
|
|
|
|
A03BA04
|
Belladonna total alkaloids
|
|
|
|
A03BB
|
|
Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
|
|
|
|
|
A03BB01
|
Butylscopolamine
|
|
|
|
|
A03BB02
|
Methylatropine
|
|
|
|
|
A03BB03
|
Methylscopolamine
|
|
|
|
|
A03BB04
|
Fentonium
|
|
|
|
|
A03BB05
|
Cimetropium bromide
|
|
|
A03C
|
|
|
Antispasmodics in combination with psycholeptics
|
|
|
|
A03CA
|
|
Synthetic anticholinergic agents in combination with psycholeptics
|
|
|
|
|
A03CA01
|
Isopropamide and psycholeptics
|
|
|
|
|
A03CA02
|
Clidinium and psycholeptics
|
|
|
|
|
A03CA03
|
Oxyphencyclimine and psycholeptics
|
|
|
|
|
A03CA04
|
Otilonium bromide and psycholeptics
|
|
|
|
|
A03CA05
|
Glycopyrronium and psycholeptics
|
|
|
|
|
A03CA06
|
Bevonium and psycholeptics
|
|
|
|
|
A03CA07
|
Ambutonium and psycholeptics
|
|
|
|
|
A03CA08
|
Diphemanil and psycholeptics
|
|
|
|
|
A03CA30
|
Emepronium and psycholeptics
|
|
|
|
|
A03CA34
|
Propantheline and psycholeptics
|
|
|
|
A03CB
|
|
Belladonna and derivatives in combination with psycholeptics
|
|
|
|
|
A03CB01
|
Methylscopolamine and psycholeptics
|
|
|
|
|
A03CB02
|
Belladonna total alkaloids and psycholeptics
|
|
|
|
|
A03CB03
|
Atropine and psycholeptics
|
|
|
|
|
A03CB04
|
Methylhomatropine and psycholeptics
|
|
|
|
|
A03CB31
|
Hyoscyamine and psycholeptics
|
|
|
|
A03CC
|
|
Other antispasmodics in combination with psycholeptics
|
|
|
|
|
|
empty
|
|
|
A03D
|
|
|
Antispasmodics in combination with analgesics
|
|
|
|
A03DA
|
|
Synthetic anticholinergic agents in combination with analgesics
|
|
|
|
|
A03DA01
|
Tropenzilone and analgesics
|
|
|
|
|
A03DA02
|
Pitofenone and analgesics
|
|
|
|
|
A03DA03
|
Bevonium and analgesics
|
|
|
|
|
A03DA04
|
Ciclonium and analgesics
|
|
|
|
|
A03DA05
|
Camylofin and analgesics
|
|
|
|
|
A03DA06
|
Trospium and analgesics
|
|
|
|
|
A03DA07
|
Tiemonium iodide and analgesics
|
|
|
|
A03DB
|
|
Belladonna and derivatives in combination with analgesics
|
|
|
|
|
A03DB04
|
Butylscopolamine and analgesics
|
|
|
|
A03DC
|
|
Other antispasmodics in combination with analgesics
|
|
|
|
|
|
empty
|
|
|
A03E
|
|
|
Antispasmodics and anticholinergics in combination with other drugs
|
|
|
|
A03EA
|
|
Antispasmodics, psycholeptics and analgesics in combination
|
|
|
|
|
|
empty
|
|
|
|
A03ED
|
|
Antispasmodics in combination with other drugs
|
|
|
|
|
|
empty
|
|
|
A03F
|
|
|
Propulsives
|
|
|
|
A03FA
|
|
Propulsives
|
|
|
|
|
A03FA01
|
Metoclopramide
|
|
|
|
|
A03FA02
|
Cisapride
|
|
|
|
|
A03FA03
|
Domperidone
|
|
|
|
|
A03FA04
|
Bromopride
|
|
|
|
|
A03FA05
|
Alizapride
|
|
|
|
|
A03FA06
|
Clebopride
|
|
A04
|
|
|
|
Antiemetics and antinauseants
|
|
|
A04A
|
|
|
Antiemetics and antinauseants
|
|
|
|
A04AA
|
|
Serotonin (5-HT3) antagonists
|
|
|
|
|
A04AA01
|
Ondansetron
|
|
|
|
|
A04AA02
|
Granisetron
|
|
|
|
|
A04AA03
|
Tropisetron
|
|
|
|
|
A04AA04
|
Dolasetron
|
|
|
|
|
A04AA05
|
Palonosetron
|
|
|
|
A04AD
|
|
Other antiemetics
|
|
|
|
|
A04AD01
|
Scopolamine
|
|
|
|
|
A04AD02
|
Cerium oxalate
|
|
|
|
|
A04AD04
|
Chlorobutanol
|
|
|
|
|
A04AD05
|
Metopimazine
|
|
|
|
|
A04AD10
|
Dronabinol
|
|
|
|
|
A04AD11
|
Nabilone
|
|
|
|
|
A04AD12
|
Aprepitant
|
|
|
|
|
A04AD13
|
Casopitant
|
|
|
|
|
A04AD51
|
Scopolamine, combinations
|
|
|
|
|
A04AD54
|
Chlorobutanol, combinations
|
|
A05
|
|
|
|
Bile and liver therapy
|
|
|
A05A
|
|
|
Bile therapy
|
|
|
|
A05AA
|
|
Bile acid preparations
|
|
|
|
|
A05AA01
|
Chenodeoxycholic acid
|
|
|
|
|
A05AA02
|
Ursodeoxycholic acid
|
|
|
|
|
A05AA03
|
Cholic acid
|
|
|
|
A05AB
|
|
Preparations for biliary tract therapy
|
|
|
|
|
A05AB01
|
Nicotinyl methylamide
|
|
|
|
A05AX
|
|
Other drugs for bile therapy
|
|
|
|
|
A05AX01
|
Piprozolin
|
|
|
|
|
A05AX02
|
Hymecromone
|
|
|
|
|
A05AX03
|
Cyclobutyrol
|
|
|
A05B
|
|
|
Liver therapy, lipotropics
|
|
|
|
A05BA
|
|
Liver therapy
|
|
|
|
|
A05BA01
|
Arginine glutamate
|
|
|
|
|
A05BA03
|
Silymarin
|
|
|
|
|
A05BA04
|
Citiolone
|
|
|
|
|
A05BA05
|
Epomediol
|
|
|
|
|
A05BA06
|
Ornithine oxoglutarate
|
|
|
|
|
A05BA07
|
Tidiacic arginine
|
|
|
|
|
A05BA08
|
Glycyrrhizic acid (glycyrrhizin)
|
|
|
A05C
|
|
|
Drugs for bile therapy and lipotropics in combination
|
|
|
|
|
|
Empty
|
|
A06
|
|
|
|
Drugs for constipation
|
|
|
A06A
|
|
|
Drugs for constipation
|
|
|
|
A06AA
|
|
Softeners, emollients
|
|
|
|
|
A06AA01
|
Liquid paraffin
|
|
|
|
|
A06AA02
|
Docusate sodium
|
|
|
|
|
A06AA51
|
Liquid paraffin, combinations
|
|
|
|
A06AB
|
|
Contact laxatives
|
|
|
|
|
A06AB01
|
Oxyphenisatine
|
|
|
|
|
A06AB02
|
Bisacodyl
|
|
|
|
|
A06AB03
|
Dantron
|
|
|
|
|
A06AB04
|
Phenolphthalein
|
|
|
|
|
A06AB05
|
Castor oil
|
|
|
|
|
A06AB06
|
Senna glycosides
|
|
|
|
|
A06AB07
|
Cascara
|
|
|
|
|
A06AB08
|
Sodium picosulfate
|
|
|
|
|
A06AB09
|
Bisoxatin
|
|
|
|
|
A06AB20
|
Contact laxatives in combination
|
|
|
|
|
A06AB30
|
Contact laxatives in combination with belladonna alkaloids
|
|
|
|
|
A06AB52
|
Bisacodyl, combinations
|
|
|
|
|
A06AB53
|
Dantron, combinations
|
|
|
|
|
A06AB56
|
Senna glycosides, combinations
|
|
|
|
|
A06AB57
|
Cascara, combinations
|
|
|
|
|
A06AB58
|
Sodium picosulfate, combinations
|
|
|
|
A06AC
|
|
Bulk-forming laxatives
|
|
|
|
|
A06AC01
|
Ispaghula (psylla seeds)
|
|
|
|
|
A06AC02
|
Ethulose
|
|
|
|
|
A06AC03
|
Sterculia
|
|
|
|
|
A06AC05
|
Linseed
|
|
|
|
|
A06AC06
|
Methylcellulose
|
|
|
|
|
A06AC07
|
Triticum (wheat fibre)
|
|
|
|
|
A06AC08
|
Polycarbophil calcium
|
|
|
|
|
A06AC51
|
Ispaghula, combinations
|
|
|
|
|
A06AC53
|
Sterculia, combinations
|
|
|
|
|
A06AC55
|
Linseed, combinations
|
|
|
|
A06AD
|
|
Osmotically acting laxatives
|
|
|
|
|
A06AD01
|
Magnesium carbonate
|
|
|
|
|
A06AD02
|
Magnesium oxide
|
|
|
|
|
A06AD03
|
Magnesium peroxide
|
|
|
|
|
A06AD04
|
Magnesium sulfate
|
|
|
|
|
A06AD10
|
Mineral salts in combination
|
|
|
|
|
A06AD11
|
Lactulose
|
|
|
|
|
A06AD12
|
Lactitol
|
|
|
|
|
A06AD13
|
Sodium sulfate
|
|
|
|
|
A06AD14
|
Pentaerithrityl
|
|
|
|
|
A06AD15
|
Macrogol
|
|
|
|
|
A06AD16
|
Mannitol
|
|
|
|
|
A06AD17
|
Sodium phosphate
|
|
|
|
|
A06AD18
|
Sorbitol
|
|
|
|
|
A06AD19
|
Magnesium citrate
|
|
|
|
|
A06AD21
|
Sodium tartrate
|
|
|
|
|
A06AD61
|
Lactulose, combinations
|
|
|
|
|
A06AD65
|
Macrogol, combinations
|
|
|
|
A06AG
|
|
Enemas
|
|
|
|
|
A06AG01
|
Sodium phosphate
|
|
|
|
|
A06AG02
|
Bisacodyl
|
|
|
|
|
A06AG03
|
Dantron, including combinations
|
|
|
|
|
A06AG04
|
Glycerol
|
|
|
|
|
A06AG06
|
Oil
|
|
|
|
|
A06AG07
|
Sorbitol
|
|
|
|
|
A06AG10
|
Docusate sodium, including combinations
|
|
|
|
|
A06AG11
|
Laurilsulfate, including combinations
|
|
|
|
|
A06AG20
|
Combinations
|
|
|
|
A06AH
|
|
Peripheral opioid receptor antagonists
|
|
|
|
|
A06AH01
|
Methylnaltrexone bromide
|
|
|
|
|
A06AH02
|
Alvimopan
|
|
|
|
A06AX
|
|
Other drugs for constipation
|
|
|
|
|
A06AX01
|
Glycerol
|
|
|
|
|
A06AX02
|
Carbon dioxide producing drugs
|
|
|
|
|
A06AX03
|
Lubiprostone
|
|
|
|
|
A06AX04
|
Linaclotide
|
|
|
|
|
A06AX05
|
Prucalopride
|
|
|
|
|
A06AX06
|
Tegaserod
|
|
A07
|
|
|
|
Antidiarrheals, intestinal anti-inflammatory/anti-infective agents
|
|
|
|
|
|
להשלים
|
|
A08
|
|
|
|
Antiobesity preparations, excluding diet products
|
|
|
|
|
|
להשלים
|
|
A09
|
|
|
|
Digestives,including enzymes
|
|
|
|
|
|
להשלים
|
|
A10
|
|
|
|
Drugs used in diabetes
|
|
|
A10A
|
|
|
Insulins and analogues
|
|
|
|
A10AB
|
|
Insulins and analogues for injection, fast-acting
|
|
|
|
|
A10AB01
|
Insulin (human)
|
|
|
|
|
A10AB02
|
Insulin (beef)
|
|
|
|
|
A10AB03
|
Insulin (pork)
|
|
|
|
|
A10AB04
|
Insulin lispro
|
|
|
|
|
A10AB05
|
Insulin aspart
|
|
|
|
|
A10AB06
|
Insulin glulisine
|
|
|
|
|
A10AB30
|
Combinations
|
|
|
|
A10AC
|
|
Insulins and analogues for injection, intermediate-acting
|
|
|
|
|
A10AC01
|
Insulin (human)
|
|
|
|
|
A10AC02
|
Insulin (beef)
|
|
|
|
|
A10AC03
|
Insulin (pork)
|
|
|
|
|
A10AC04
|
Insulin lispro
|
|
|
|
|
A10AC30
|
Combinations
|
|
|
|
A10AD
|
|
Insulins and analogues for injection, intermediate-acting combined with fast-acting
|
|
|
|
|
A10AD01
|
Insulin (human)
|
|
|
|
|
A10AD02
|
Insulin (beef)
|
|
|
|
|
A10AD03
|
Insulin (pork)
|
|
|
|
|
A10AD04
|
Insulin lispro
|
|
|
|
|
A10AD05
|
Insulin aspart
|
|
|
|
|
A10AD30
|
Combinations
|
|
|
|
A10AE
|
|
Insulins and analogues for injection, long-acting
|
|
|
|
|
A10AE01
|
Insulin (human)
|
|
|
|
|
A10AE02
|
Insulin (beef)
|
|
|
|
|
A10AE03
|
Insulin (pork)
|
|
|
|
|
A10AE04
|
Insulin glargine
|
|
|
|
|
A10AE05
|
Insulin detemir
|
|
|
|
|
A10AE30
|
Combinations
|
|
|
|
A10AF
|
|
Insulins and analogues for inhalation
|
|
|
|
|
A10AF01
|
Insulin (human)
|
|
|
A10B
|
|
|
Blood glucose lowering drugs, excluding insulins
|
|
|
|
A10BA
|
|
Biguanides
|
|
|
|
|
A10BA01
|
Phenformin
|
|
|
|
|
A10BA02
|
Metformin
|
|
|
|
|
A10BA03
|
Buformin
|
|
|
|
A10BB
|
|
Sulfonamides, urea derivatives
|
|
|
|
|
A10BB01
|
Glibenclamide
|
|
|
|
|
A10BB02
|
Chlorpropamide
|
|
|
|
|
A10BB03
|
Tolbutamide
|
|
|
|
|
A10BB04
|
Glibornuride
|
|
|
|
|
A10BB05
|
Tolazamide
|
|
|
|
|
A10BB06
|
Carbutamide
|
|
|
|
|
A10BB07
|
Glipizide
|
|
|
|
|
A10BB08
|
Gliquidone
|
|
|
|
|
A10BB09
|
Gliclazide
|
|
|
|
|
A10BB10
|
Metahexamide
|
|
|
|
|
A10BB11
|
Glisoxepide
|
|
|
|
|
A10BB12
|
Glimepiride
|
|
|
|
|
A10BB31
|
Acetohexamide
|
|
|
|
A10BC
|
|
Sulfonamides (heterocyclic)
|
|
|
|
|
A10BC01
|
Glymidine
|
|
|
|
A10BD
|
|
Combinations of oral blood glucose lowering drugs
|
|
|
|
|
A10BD01
|
Phenformin and sulfonamides
|
|
|
|
|
A10BD02
|
Metformin and sulfonamides
|
|
|
|
|
A10BD03
|
Metformin and rosiglitazone
|
|
|
|
|
A10BD04
|
Glimepiride and rosiglitazone
|
|
|
|
|
A10BD05
|
Metformin and pioglitazone
|
|
|
|
|
A10BD06
|
Glimepiride and pioglitazone
|
|
|
|
|
A10BD07
|
Metformin and sitagliptin
|
|
|
|
|
A10BD08
|
Metformin and vildagliptin
|
|
|
|
|
A10BD09
|
Pioglitazone and alogliptin
|
|
|
|
|
A10BD10
|
Metformin and saxagliptin
|
|
|
|
|
A10BD11
|
Metformin and linagliptin
|
|
|
|
|
A10BD12
|
Pioglitazone and sitagliptin
|
|
|
|
|
A10BD13
|
Metformin and alogliptin
|
|
|
|
A10BF
|
|
Alpha glucosidase inhibitors
|
|
|
|
|
A10BF01
|
Acarbose
|
|
|
|
|
A10BF02
|
Miglitol
|
|
|
|
|
A10BF03
|
Voglibose
|
|
|
|
A10BG
|
|
Thiazolidinediones
|
|
|
|
|
A10BG01
|
Troglitazone
|
|
|
|
|
A10BG02
|
Rosiglitazone
|
|
|
|
|
A10BG03
|
Pioglitazone
|
|
|
|
A10BH
|
|
Dipeptidyl peptidase 4 (DPP-4) inhibitors
|
|
|
|
|
A10BH01
|
Sitagliptin
|
|
|
|
|
A10BH02
|
Vildagliptin
|
|
|
|
|
A10BH03
|
Saxagliptin
|
|
|
|
|
A10BH04
|
Alogliptin
|
|
|
|
|
A10BH05
|
Linagliptin
|
|
|
|
|
A10BH51
|
Sitagliptin and simvastatin
|
|
|
|
A10BX
|
|
Other blood glucose lowering drugs, excluding insulins
|
|
|
|
|
A10BX01
|
Guar gum
|
|
|
|
|
A10BX02
|
Repaglinide
|
|
|
|
|
A10BX03
|
Nateglinide
|
|
|
|
|
A10BX04
|
Exenatide
|
|
|
|
|
A10BX05
|
Pramlintide
|
|
|
|
|
A10BX06
|
Benfluorex
|
|
|
|
|
A10BX07
|
Liraglutide
|
|
|
|
|
A10BX08
|
Mitiglinide
|
|
|
|
|
A10BX09
|
Dapagliflozin
|
|
|
A10X
|
|
|
Other drugs used in diabetes
|
|
|
|
A10XA
|
|
Aldose reductase inhibitors
|
|
|
|
|
A10XA01
|
Tolrestat
|
|
A11
|
|
|
|
Vitamins
|
|
|
|
|
|
להשלים
|
|
A12
|
|
|
|
Mineral supplements
|
|
|
A12A
|
|
|
ֻCalcium
|
|
|
|
|
|
להשלים
|
|
|
A12B
|
|
|
Potassium
|
|
|
|
|
|
להשלים
|
|
|
A12C
|
|
|
Other mineral supplements
|
|
|
|
A12CA
|
|
Sodium
|
|
|
|
|
|
להשלים
|
|
|
|
A12CB
|
|
Zinc
|
|
|
|
|
|
להשלים
|
|
|
|
A12CC
|
|
Magnesium
|
|
|
|
|
|
להשלים
|
|
|
|
A12CD
|
|
Fluoride
|
|
|
|
|
|
להשלים
|
|
|
|
A12CE
|
|
Selenium
|
|
|
|
|
|
להשלים
|
|
|
|
A12CX
|
|
Other mineral products
|
|
|
|
|
|
להשלים
|
|
A13
|
|
|
|
Tonics
|
|
|
A13A
|
|
|
Tonics
|
|
|
|
|
|
empty
|
|
A14
|
|
|
|
Anabolic agents for systemic use
|
|
|
|
|
|
להשלים
|
|
A15
|
|
|
|
Appetite stimulants
|
|
|
|
|
|
empty
|
|
A16
|
|
|
|
Other alimentary tract and metabolism products
|
|
|
|
|
|
להשלים
|
B
|
|
|
|
|
Blood and blood forming organs
|
|
B01
|
|
|
|
Antithrombotic agents
|
|
|
B01A
|
|
|
Antithrombotic agents
|
|
|
|
B01AA
|
|
Vitamin K antagonists
|
|
|
|
|
B01AA01
|
Dicoumarol
|
|
|
|
|
B01AA02
|
Phenindione
|
|
|
|
|
B01AA03
|
Warfarin
|
|
|
|
|
B01AA04
|
Phenprocoumon
|
|
|
|
|
B01AA07
|
Acenocoumarol
|
|
|
|
|
B01AA08
|
Ethyl biscoumacetate
|
|
|
|
|
B01AA09
|
Clorindione
|
|
|
|
|
B01AA10
|
Diphenadione
|
|
|
|
|
B01AA11
|
Tioclomarol
|
|
|
|
|
B01AA12
|
Fluindione
|
|
|
|
B01AB
|
|
Heparin group
|
|
|
|
|
B01AB01
|
Heparin
|
|
|
|
|
B01AB02
|
Antithrombin III
|
|
|
|
|
B01AB04
|
Dalteparin
|
|
|
|
|
B01AB05
|
Enoxaparin
|
|
|
|
|
B01AB06
|
Nadroparin
|
|
|
|
|
B01AB07
|
Parnaparin
|
|
|
|
|
B01AB08
|
Reviparin
|
|
|
|
|
B01AB09
|
Danaparoid
|
|
|
|
|
B01AB10
|
Tinzaparin
|
|
|
|
|
B01AB11
|
Sulodexide
|
|
|
|
|
B01AB12
|
Bemiparin
|
|
|
|
|
B01AB51
|
Heparin, combinations
|
|
|
|
B01AC
|
|
Platelet aggregation inhibitors excluding heparin
|
|
|
|
|
B01AC01
|
Ditazole
|
|
|
|
|
B01AC02
|
Cloricromen
|
|
|
|
|
B01AC03
|
Picotamide
|
|
|
|
|
B01AC04
|
Clopidogrel
|
|
|
|
|
B01AC05
|
Ticlopidine
|
|
|
|
|
B01AC06
|
Acetylsalicylic acid
|
|
|
|
|
B01AC07
|
Dipyridamole
|
|
|
|
|
B01AC08
|
Carbasalate calcium
|
|
|
|
|
B01AC09
|
Epoprostenol
|
|
|
|
|
B01AC10
|
Indobufen
|
|
|
|
|
B01AC11
|
Iloprost
|
|
|
|
|
B01AC13
|
Abciximab
|
|
|
|
|
B01AC15
|
Aloxiprin
|
|
|
|
|
B01AC16
|
Eptifibatide
|
|
|
|
|
B01AC17
|
Tirofiban
|
|
|
|
|
B01AC18
|
Triflusal
|
|
|
|
|
B01AC19
|
Beraprost
|
|
|
|
|
B01AC21
|
Treprostinil
|
|
|
|
|
B01AC22
|
Prasugrel
|
|
|
|
|
B01AC23
|
Cilostazol
|
|
|
|
|
B01AC24
|
Ticagrelor
|
|
|
|
|
B01AC30
|
Combinations
|
|
|
|
|
B01AC56
|
Acetylsalicylic acid and esomeprazole
|
|
|
|
B01AD
|
|
Enzymes
|
|
|
|
|
B01AD01
|
Streptokinase
|
|
|
|
|
B01AD02
|
Alteplase
|
|
|
|
|
B01AD03
|
Anistreplase
|
|
|
|
|
B01AD04
|
Urokinase
|
|
|
|
|
B01AD05
|
Fibrinolysin
|
|
|
|
|
B01AD06
|
Brinase
|
|
|
|
|
B01AD07
|
Reteplase
|
|
|
|
|
B01AD08
|
Saruplase
|
|
|
|
|
B01AD09
|
Ancrod
|
|
|
|
|
B01AD10
|
Drotrecogin alfa (activated)
|
|
|
|
|
B01AD11
|
Tenecteplase
|
|
|
|
|
B01AD12
|
Protein C
|
|
|
|
B01AE
|
|
Direct thrombin inhibitors
|
|
|
|
|
B01AE01
|
Desirudin
|
|
|
|
|
B01AE02
|
Lepirudin
|
|
|
|
|
B01AE03
|
Argatroban
|
|
|
|
|
B01AE04
|
Melagatran
|
|
|
|
|
B01AE05
|
Ximelagatran
|
|
|
|
|
B01AE06
|
Bivalirudin
|
|
|
|
|
B01AE07
|
Dabigatran etexilate
|
|
|
|
B01AF
|
|
Direct factor Xa inhibitors
|
|
|
|
|
B01AF01
|
Rivaroxaban
|
|
|
|
|
B01AF02
|
Apixaban
|
|
|
|
B01AX
|
|
Other antithrombotic agents
|
|
|
|
|
B01AX01
|
Defibrotide
|
|
|
|
|
B01AX04
|
Dermatan sulfate
|
|
|
|
|
B01AX05
|
Fondaparinux
|
|
B02
|
|
|
|
Antihemorrhagics
|
|
B03
|
|
|
|
Antianemic preparations
|
|
B05
|
|
|
|
Blood substitutes and perfusion solutions
|
|
|
B05A
|
|
|
Blood and related products
|
|
|
|
B05AA
|
|
Blood substitutes and plasma protein fractions
|
|
|
|
|
B05AA01
|
Serum albumin
|
|
|
|
|
B05AA02
|
Other plasma protein fractions
|
|
|
|
|
B05AA03
|
Fluorocarbon blood substitutes
|
|
|
|
|
B05AA05
|
Dextran
|
|
|
|
|
B05AA06
|
Gelatin agents
|
|
|
|
|
B05AA07
|
Hydroxyethylstarch
|
|
|
|
|
B05AA08
|
Hemoglobin crosfumaril
|
|
|
|
|
B05AA09
|
Hemoglobin raffimer
|
|
|
|
|
B05AA10
|
Hemoglobin glutamer (bovine)
|
|
|
|
B05AX
|
|
Other blood products
|
|
|
|
|
B05AX01
|
Erythrocytes
|
|
|
|
|
B05AX02
|
Thrombocytes
|
|
|
|
|
B05AX03
|
Blood plasma
|
|
|
|
|
B05AX04
|
Stem cells from umbilical cord blood
|
|
|
B05B
|
|
|
I.v. solutions
|
|
|
|
B05BA
|
|
Solutions for parenteral nutrition
|
|
|
|
|
B05BA01
|
Amino acids
|
|
|
|
|
B05BA02
|
Fat emulsions
|
|
|
|
|
B05BA03
|
Carbohydrates
|
|
|
|
|
B05BA04
|
Protein hydrolysates
|
|
|
|
|
B05BA10
|
Combinations
|
|
|
|
B05BB
|
|
Solutions affecting the electrolyte balance
|
|
|
|
|
B05BB01
|
Electrolytes
|
|
|
|
|
B05BB02
|
Electrolytes with carbohydrates
|
|
|
|
|
B05BB03
|
Trometamol
|
|
|
|
|
B05BB04
|
Electrolytes in combination with other drugs
|
|
|
|
B05BC
|
|
Solutions producing osmotic diuresis
|
|
|
|
|
B05BC01
|
Mannitol
|
|
|
|
|
B05BC02
|
Carbamide
|
|
|
B05C
|
|
|
Irrigating solutions
|
|
|
|
B05CA
|
|
Antiinfectives
|
|
|
|
|
B05CA01
|
Cetylpyridinium
|
|
|
|
|
B05CA02
|
Chlorhexidine
|
|
|
|
|
B05CA03
|
Nitrofural
|
|
|
|
|
B05CA04
|
Sulfamethizole
|
|
|
|
|
B05CA05
|
Taurolidine
|
|
|
|
|
B05CA06
|
Mandelic acid
|
|
|
|
|
B05CA07
|
Noxytiolin
|
|
|
|
|
B05CA08
|
Ethacridine lactate
|
|
|
|
|
B05CA09
|
Neomycin
|
|
|
|
|
B05CA10
|
Combinations
|
|
|
|
B05CB
|
|
Salt solutions
|
|
|
|
|
B05CB01
|
Sodium chloride
|
|
|
|
|
B05CB02
|
Sodium citrate
|
|
|
|
|
B05CB03
|
Magnesium citrate
|
|
|
|
|
B05CB04
|
Sodium bicarbonate
|
|
|
|
|
B05CB10
|
Combinations
|
|
|
|
B05CX
|
|
Other irrigating solutions
|
|
|
|
|
B05CX01
|
Glucose
|
|
|
|
|
B05CX02
|
Sorbitol
|
|
|
|
|
B05CX03
|
Glycine
|
|
|
|
|
B05CX04
|
Mannitol
|
|
|
|
|
B05CX10
|
Combinations
|
|
|
B05D
|
|
|
Peritoneal dialytics
|
|
|
|
B05DA
|
|
Isotonic solutions
|
|
|
|
B05DB
|
|
Hypertonic solutions
|
|
|
B05X
|
|
|
I.v. solution additives
|
|
|
|
B05XA
|
|
Electrolyte solutions
|
|
|
|
|
B05XA01
|
Potassium chloride
|
|
|
|
|
B05XA02
|
Sodium bicarbonate
|
|
|
|
|
B05XA03
|
Sodium chloride
|
|
|
|
|
B05XA04
|
Ammonium chloride
|
|
|
|
|
B05XA05
|
Magnesium sulfate
|
|
|
|
|
B05XA06
|
Potassium phosphate, including combinations with other potassium salts
|
|
|
|
|
B05XA07
|
Calcium chloride
|
|
|
|
|
B05XA08
|
Sodium acetate
|
|
|
|
|
B05XA09
|
Sodium phosphate
|
|
|
|
|
B05XA10
|
Magnesium phosphate
|
|
|
|
|
B05XA11
|
Magnesium chloride
|
|
|
|
|
B05XA12
|
Zinc chloride
|
|
|
|
|
B05XA13
|
Hydrochloric acid
|
|
|
|
|
B05XA14
|
Sodium glycerophosphate
|
|
|
|
|
B05XA15
|
Potassium lactate
|
|
|
|
|
B05XA16
|
Cardioplegia solutions
|
|
|
|
|
B05XA17
|
Potassium acetate
|
|
|
|
|
B05XA30
|
Combinations of electrolytes
|
|
|
|
|
B05XA31
|
Electrolytes in combination with other drugs
|
|
|
|
B05XB
|
|
Amino acids
|
|
|
|
|
B05XB01
|
Arginine hydrochloride
|
|
|
|
|
B05XB02
|
Alanyl glutamine
|
|
|
|
|
B05XB03
|
Lysine
|
|
|
|
B05XC
|
|
Vitamins
|
|
|
|
B05XX
|
|
Other i.v. solution additives
|
|
|
|
|
B05XX02
|
Trometamol
|
|
|
B05Z
|
|
|
Hemodialytics and hemofiltrates
|
|
|
|
B05ZA
|
|
Hemodialytics, concentrates
|
|
|
|
B05ZB
|
|
Hemofiltrates
|
|
B06
|
|
|
|
Other hematological agents
|
C
|
|
|
|
|
Cardiovascular system
|
|
C01
|
|
|
|
Cardiac therapy
|
|
C02
|
|
|
|
Antihypertensives
|
|
C03
|
|
|
|
Diuretics
|
|
C04
|
|
|
|
Peripheral vasodilators
|
|
|
C04A
|
|
|
Peripheral vasodilators
|
|
|
|
C04AA
|
|
2-amino-1-phenylethanol derivatives
C04AA01 Isoxsuprine
C04AA02 Buphenine
C04AA31 Bamethan
|
|
|
C04AB
|
|
Imidazoline derivatives
C04AB01 Phentolamine
C04AB02 Tolazoline
|
|
|
C04AC
|
|
Nicotinic acid and derivatives
C04AC01 Nicotinic acid
C04AC02 Nicotinyl alcohol (pyridylcarbinol)
C04AC03 Inositol nicotinate
C04AC07 Ciclonicate
|
|
|
C04AD
|
|
Purine derivatives
C04AD01 Pentifylline
C04AD02 Xantinol nicotinate
C04AD03 Pentoxifylline
C04AD04 Etofylline nicotinate
|
|
|
C04AE
|
|
Ergot alkaloids
C04AE01 Ergoloid mesylates
C04AE02 Nicergoline
C04AE04 Dihydroergocristine
C04AE51 Ergoloid mesylates, combinations
C04AE54 Dihydroergocristine, combinations
|
|
|
C04AF
|
|
Enzymes
C04AF01 Kallidinogenase
|
|
|
C04AX
|
Other peripheral vasodilators
C04AX01 Cyclandelate
C04AX02 Phenoxybenzamine
C04AX07 Vincamine
C04AX10 Moxisylyte
C04AX11 Bencyclane
C04AX17 Vinburnine
C04AX19 Sulcotidil
C04AX20 Buflomedil
C04AX21 Naftidrofuryl
C04AX23 Butalamine
C04AX24 Visnadine
C04AX26 Cetiedil
C04AX27 Cinepazide
C04AX28 Ifenprodil
C04AX30 Azapetine
C04AX32 Fasudil
|
|
C05
|
|
|
|
Vasoprotectives
|
|
C07
|
|
|
|
Beta blocking agents
|
|
C08
|
|
|
|
Calcium channel blockers
|
|
C09
|
|
|
|
Agents acting on the renin-angiotensin system
|
|
C10
|
|
|
|
Lipid modifying agents
|
|
|
C10A
|
|
|
Lipid modifying agents, plain
|
|
|
|
C10AA
|
|
HMG CoA reductase inhibitors
|
|
|
|
C10AB
|
|
Fibrates
|
|
|
|
C10AC
|
|
Bile acid sequestrants
|
|
|
|
|
C10AC01
|
Colestyramine
|
|
|
|
|
C10AC02
|
Colestipol
|
|
|
|
|
C10AC03
|
Colextran
|
|
|
|
|
C10AC04
|
Colesevelam
|
|
|
|
C10AD
|
|
Nicotinic acid and derivatives
|
|
|
|
C10AX
|
|
Other lipid modifying agents
|
|
|
C10B
|
|
|
Lipid modifying agents, combinations
|
D
|
|
|
|
|
Dermatologicals
|
|
D01
|
|
|
|
Antifungals for dermatological use
|
|
D02
|
|
|
|
Emollients and protectives
|
|
D03
|
|
|
|
Preparations for treatment of wounds and ulcers
|
|
D04
|
|
|
|
Antipruritics, including antihistamines, anesthetics, etc
|
|
D05
|
|
|
|
Antipsoriatics
|
|
D06
|
|
|
|
Antibiotics and chemotherapeutics for dermatological use
|
|
D07
|
|
|
|
Corticosteroids, dermatological preparations
|
|
D08
|
|
|
|
Antiseptics and disinfectants
|
|
D09
|
|
|
|
Medicated dressings
|
|
D10
|
|
|
|
Anti-acne preparations
|
|
D11
|
|
|
|
Other dermatological preparations
|
G
|
|
|
|
|
Genito-urinary system and sex hormones
|
|
G01
|
|
|
|
Gynecological antiinfectives and antiseptics
|
|
G02
|
|
|
|
Other gynecologicals
|
|
G03
|
|
|
|
Sex hormones and modulators of the genital system
|
|
G04
|
|
|
|
Urologicals
|
|
|
G04B
|
|
|
Urologicals
|
|
|
|
G04BA
|
|
Acidifiers
|
|
|
|
G04BC
|
|
Urinary concrement solvents
|
|
|
|
G04BD
|
|
Drugs for urinary frequency and incontinence
|
|
|
|
|
G04BD01
|
Emepronium
|
|
|
|
|
G04BD02
|
Flavoxate
|
|
|
|
|
G04BD03
|
Meladrazine
|
|
|
|
|
G04BD04
|
Oxybutynin
|
|
|
|
|
G04BD05
|
Terodiline
|
|
|
|
|
G04BD06
|
Propiverine
|
|
|
|
|
G04BD07
|
Tolterodine
|
|
|
|
|
G04BD08
|
Solifenacin
|
|
|
|
|
G04BD09
|
Trospium
|
|
|
|
|
G04BD10
|
Darifenacin
|
|
|
|
|
G04BD11
|
Fesoterodine
|
|
|
|
|
G04BD12
|
Mirabegron
|
|
|
|
G04BE
|
|
Drugs used in erectile dysfunction
|
|
|
|
|
G04BE01
|
Alprostadil
|
|
|
|
|
G04BE02
|
Papaverine
|
|
|
|
|
G04BE03
|
Sildenafil
|
|
|
|
|
G04BE04
|
Yohimbin
|
|
|
|
|
G04BE06
|
Moxisylyte
|
|
|
|
|
G04BE07
|
Apomorphine
|
|
|
|
|
G04BE08
|
Tadalafil
|
|
|
|
|
G04BE09
|
Vardenafil
|
|
|
|
|
G04BE30
|
Combinations
|
|
|
|
|
G04BE52
|
Papaverine, combinations
|
|
|
|
G04BX
|
|
Other urologicals
|
|
|
|
|
|
להשלים
|
|
|
G04C
|
|
|
Drugs used in benign prostatic hypertrophy
|
|
|
|
G04CA
|
|
Alpha-adrenoreceptor antagonists
|
|
|
|
G04CB
|
|
Testosterone-5-alpha reductase inhibitors
|
|
|
|
G04CX
|
|
Other drugs used in benign prostatic hypertrophy
|
H
|
|
|
|
|
Systemic hormonal preparations, excluding sex hormones and insulins
|
|
H01
|
|
|
|
Pituitary and hypothalamic hormones and analogues
|
|
H02
|
|
|
|
Corticosteroids for systemic use
|
|
H03
|
|
|
|
Thyroid therapy
|
|
H04
|
|
|
|
Pancreatic hormones
|
|
H05
|
|
|
|
Calcium homeostasis
|
J
|
|
|
|
|
Antiinfectives for systemic use
|
|
J01
|
|
|
|
Antibacterials for systemic use
|
|
|
J01A
|
|
|
Tetracyclines
|
|
|
J01B
|
|
|
Amphenicols
|
|
|
J01C
|
|
|
Beta-lactam antibacterials, penicillins
|
|
|
J01D
|
|
|
Other beta-lactam antibacterials
|
|
|
J01E
|
|
|
Sulfonamides and trimethoprim
|
|
|
J01F
|
|
|
Macrolides, lincosamides and streptogramins
|
|
|
J01G
|
|
|
Aminoglycoside antibacterials
|
|
|
J01M
|
|
|
Quinolone antibacterials
|
|
|
J01R
|
|
|
Combinations of antibacterials
|
|
|
J01X
|
|
|
Other antibacterials
|
|
|
|
J01XA
|
|
Glycopeptide antibacterials
|
|
|
|
J01XB
|
|
Polymyxins
|
|
|
|
J01XC
|
|
Steroid antibacterials
|
|
|
|
J01XD
|
|
Imidazole derivatives
|
|
|
|
J01XE
|
|
Nitrofuran derivatives
|
|
|
|
J01XX
|
|
Other antibacterials
|
|
J02
|
|
|
|
Antimycotics for systemic use
|
|
J04
|
|
|
|
Antimycobacterials
|
|
J05
|
|
|
|
Antivirals for systemic use
|
|
|
J05A
|
|
|
Direct acting antiviral drugs
|
|
|
|
J05AA
|
|
Thiosemicarbazones
|
|
|
|
J05AB
|
|
Nucleosides and nucleotides excluding reverse transcriptase inhibitors
|
|
|
|
J05AC
|
|
Cyclic amines
|
|
|
|
J05AD
|
|
Phosphonic acid derivatives
|
|
|
|
J05AE
|
|
Protease inhibitors
|
|
|
|
J05AF
|
|
Nucleoside and nucleotide reverse transcriptase inhibitors
|
|
|
|
|
J05AF01
|
Zidovudine
|
|
|
|
|
J05AF02
|
Didanosine
|
|
|
|
|
J05AF03
|
Zalcitabine
|
|
|
|
|
J05AF04
|
Stavudine
|
|
|
|
|
J05AF05
|
Lamivudine
|
|
|
|
|
J05AF06
|
Abacavir
|
|
|
|
|
J05AF07
|
Tenofovir disoproxil
|
|
|
|
|
J05AF08
|
Adefovir dipivoxil
|
|
|
|
|
J05AF09
|
Emtricitabine
|
|
|
|
|
J05AF10
|
Entecavir
|
|
|
|
|
J05AF11
|
Telbivudine
|
|
|
|
|
J05AF12
|
Clevudine
|
|
|
|
J05AG
|
|
Non-nucleoside reverse transcriptase inhibitors
|
|
|
|
|
J05AG01
|
Nevirapine
|
|
|
|
|
J05AG02
|
Delavirdine
|
|
|
|
|
J05AG03
|
Efavirenz
|
|
|
|
|
J05AG04
|
Etravirine
|
|
|
|
|
J05AG05
|
Rilpivirine
|
|
|
|
J05AH
|
|
Neuraminidase inhibitors
|
|
|
|
|
J05AH01
|
Zanamivir
|
|
|
|
|
J05AH02
|
Oseltamivir
|
|
|
|
J05AR
|
|
Antivirals for treatment of HIV infections, combinations
|
|
|
|
|
J05AR01
|
Zidovudine and lamivudine
|
|
|
|
|
J05AR02
|
Lamivudine and abacavir
|
|
|
|
|
J05AR03
|
Tenofovir disoproxil and emtricitabine
|
|
|
|
|
J05AR04
|
Zidovudine, lamivudine and abacavir
|
|
|
|
|
J05AR05
|
Zidovudine, lamivudine and nevirapine
|
|
|
|
|
J05AR06
|
Emtricitabine, tenofovir disoproxil and efavirenz
|
|
|
|
|
J05AR07
|
Stavudine, lamivudine and nevirapine
|
|
|
|
|
J05AR08
|
Emtricitabine, tenofovir disoproxil and rilpivirine
|
|
|
|
|
J05AR09
|
Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
|
|
|
|
|
J05AR10
|
Lopinavir and ritonavir
|
|
|
|
J05AX
|
|
Other antivirals
|
|
|
|
|
J05AX01
|
Moroxydine
|
|
|
|
|
J05AX02
|
Lysozyme
|
|
|
|
|
J05AX05
|
Inosine pranobex
|
|
|
|
|
J05AX06
|
Pleconaril
|
|
|
|
|
J05AX07
|
Enfuvirtide
|
|
|
|
|
J05AX08
|
Raltegravir
|
|
|
|
|
J05AX09
|
Maraviroc
|
|
|
|
|
J05AX10
|
Maribavir
|
|
|
|
|
J05AX11
|
Elvitegravir
|
|
J06
|
|
|
|
Immune sera and immunoglobulins
|
|
|
J06A
|
|
|
Immune sera
|
|
|
|
J06AA
|
|
Immune sera
|
|
|
|
|
J06AA01
|
Diphtheria antitoxin
|
|
|
|
|
J06AA02
|
Tetanus antitoxin
|
|
|
|
|
J06AA03
|
Snake venom antiserum
|
|
|
|
|
J06AA04
|
Botulinum antitoxin
|
|
|
|
|
J06AA05
|
Gas-gangrene sera
|
|
|
|
|
J06AA06
|
Rabies serum
|
|
|
J06B
|
|
|
Immunoglobulins
|
|
|
|
J06BA
|
|
Immunoglobulins, normal human
|
|
|
|
|
J06BA01
|
Immunoglobulins, normal human, for extravascular administration
|
|
|
|
|
J06BA02
|
Immunoglobulins, normal human, for intravascular administration
|
|
|
|
J06BB
|
|
Specific immunoglobulins
|
|
|
|
|
J06BB01
|
Anti-D (rh) immunoglobulin
|
|
|
|
|
J06BB02
|
Tetanus immunoglobulin
|
|
|
|
|
J06BB03
|
Varicella/zoster immunoglobulin
|
|
|
|
|
J06BB04
|
Hepatitis B immunoglobulin
|
|
|
|
|
J06BB05
|
Rabies immunoglobulin
|
|
|
|
|
J06BB06
|
Rubella immunoglobulin
|
|
|
|
|
J06BB07
|
Vaccinia immunoglobulin
|
|
|
|
|
J06BB08
|
Staphylococcus immunoglobulin
|
|
|
|
|
J06BB09
|
Cytomegalovirus immunoglobulin
|
|
|
|
|
J06BB10
|
Diphtheria immunoglobulin
|
|
|
|
|
J06BB11
|
Hepatitis A immunoglobulin
|
|
|
|
|
J06BB12
|
Encephalitis, tick borne immunoglobulin
|
|
|
|
|
J06BB13
|
Pertussis immunoglobulin
|
|
|
|
|
J06BB14
|
Morbilli immunoglobulin
|
|
|
|
|
J06BB15
|
Parotitis immunoglobulin
|
|
|
|
|
J06BB16
|
Palivizumab
|
|
|
|
|
J06BB17
|
Motavizumab
|
|
|
|
|
J06BB30
|
Combinations
|
|
|
|
J06BC
|
|
Other immunoglobulins
|
|
|
|
|
J06BC01
|
Nebacumab
|
L
|
|
|
|
|
Antineoplastic and immunomodulating agents
|
|
L01
|
|
|
|
Antineoplastic agents
|
|
L02
|
|
|
|
Endocrine therapy
|
|
L03
|
|
|
|
Immunostimulants
|
|
L04
|
|
|
|
Immunosuppressants
|
M
|
|
|
|
|
Musculo-skeletal system
|
|
M01
|
|
|
|
Anti-inflammatory and antirheumatic products
|
|
|
M01A
|
|
|
Anti-inflammatory and antirheumatic products, non-steroids
|
|
|
|
M01AA
|
|
Butylpyrazolidines
|
|
|
|
M01AB
|
|
Acetic acid derivatives and related substances
|
|
|
|
|
M01AB01
|
Indometacin
|
|
|
|
|
M01AB02
|
Sulindac
|
|
|
|
|
M01AB03
|
Tolmetin
|
|
|
|
|
M01AB04
|
Zomepirac
|
|
|
|
|
M01AB05
|
Diclofenac
|
|
|
|
|
M01AB06
|
Alclofenac
|
|
|
|
|
M01AB07
|
Bumadizone
|
|
|
|
|
M01AB08
|
Etodolac
|
|
|
|
|
M01AB09
|
Lonazolac
|
|
|
|
|
M01AB10
|
Fentiazac
|
|
|
|
|
M01AB11
|
Acemetacin
|
|
|
|
|
M01AB12
|
Difenpiramide
|
|
|
|
|
M01AB13
|
Oxametacin
|
|
|
|
|
M01AB14
|
Proglumetacin
|
|
|
|
|
M01AB15
|
Ketorolac
|
|
|
|
|
M01AB16
|
Aceclofenac
|
|
|
|
|
M01AB17
|
Bufexamac
|
|
|
|
|
M01AB51
|
Indometacin, combinations
|
|
|
|
|
M01AB55
|
Diclofenac, combinations
|
|
|
|
M01AC
|
|
Oxicams
|
|
|
|
M01AE
|
|
Propionic acid derivatives
|
|
|
|
M01AG
|
|
Fenamates
|
|
|
|
M01AH
|
|
Coxibs
|
|
|
|
M01AX
|
|
Other anti-inflammatory and antirheumatic agents, non-steroids
|
|
|
|
|
M01AX01
|
Nabumetone
|
|
|
|
|
M01AX02
|
Niflumic acid
|
|
|
|
|
M01AX04
|
Azapropazone
|
|
|
|
|
M01AX05
|
Glucosamine
|
|
|
|
|
M01AX07
|
Benzydamine
|
|
|
|
|
M01AX12
|
Glucosaminoglycan polysulfate
|
|
|
|
|
M01AX13
|
Proquazone
|
|
|
|
|
M01AX14
|
Orgotein
|
|
|
|
|
M01AX17
|
Nimesulide
|
|
|
|
|
M01AX18
|
Feprazone
|
|
|
|
|
M01AX21
|
Diacerein
|
|
|
|
|
M01AX22
|
Morniflumate
|
|
|
|
|
M01AX23
|
Tenidap
|
|
|
|
|
M01AX24
|
Oxaceprol
|
|
|
|
|
M01AX25
|
Chondroitin sulfate
|
|
|
|
|
M01AX26
|
Avocado and soyabean oil, unsaponifiables
|
|
|
|
|
M01AX68
|
Feprazone, combinations
|
|
|
M01B
|
|
|
Anti-inflammatory/antirheumatic agents in combination
|
|
|
M01C
|
|
|
Specific antirheumatic agents
|
|
M02
|
|
|
|
Topical products for joint and muscular pain
|
|
|
M02A
|
|
|
Topical products for joint and muscular pain
|
|
|
|
M02AA
|
|
Anti-inflammatory preparations, non-steroids for topical use
|
|
|
|
|
M02AA01
|
Phenylbutazone
|
|
|
|
|
M02AA02
|
Mofebutazone
|
|
|
|
|
M02AA03
|
Clofezone
|
|
|
|
|
M02AA04
|
Oxyphenbutazone
|
|
|
|
|
M02AA05
|
Benzydamine
|
|
|
|
|
M02AA06
|
Etofenamate
|
|
|
|
|
M02AA07
|
Piroxicam
|
|
|
|
|
M02AA08
|
Felbinac
|
|
|
|
|
M02AA09
|
Bufexamac
|
|
|
|
|
M02AA10
|
Ketoprofen
|
|
|
|
|
M02AA11
|
Bendazac
|
|
|
|
|
M02AA12
|
Naproxen
|
|
|
|
|
M02AA13
|
Ibuprofen
|
|
|
|
|
M02AA14
|
Fentiazac
|
|
|
|
|
M02AA15
|
Diclofenac
|
|
|
|
|
M02AA16
|
Feprazone
|
|
|
|
|
M02AA17
|
Niflumic acid
|
|
|
|
|
M02AA18
|
Meclofenamic acid
|
|
|
|
|
M02AA19
|
Flurbiprofen
|
|
|
|
|
M02AA21
|
Tolmetin
|
|
|
|
|
M02AA22
|
Suxibuzone
|
|
|
|
|
M02AA23
|
Indometacin
|
|
|
|
|
M02AA24
|
Nifenazone
|
|
|
|
|
M02AA25
|
Aceclofenac
|
|
|
|
|
M02AA26
|
Nimesulide
|
|
|
|
M02AB
|
|
Capsaicin and similar agents
|
|
|
|
M02AC
|
|
Preparations with salicylic acid derivatives
|
|
|
|
M02AX
|
|
Other topical products for joint and muscular pain
|
|
M03
|
|
|
|
Muscle relaxants
|
|
M04
|
|
|
|
Antigout preparations
|
|
M05
|
|
|
|
Drugs for treatment of bone diseases
|
|
M09
|
|
|
|
Other drugs for disorders of the musculo-skeletal system
|
N
|
|
|
|
|
Nervous system
|
|
N01
|
|
|
|
Anesthetics
|
|
N02
|
|
|
|
Analgesics
|
|
N03
|
|
|
|
Antiepileptics
|
|
N04
|
|
|
|
Anti-parkinson drugs
|
|
N05
|
|
|
|
Psycholeptics
|
|
|
N05A
|
|
|
Antipsychotics
|
|
|
|
N05AA
|
|
Phenothiazines with aliphatic side-chain
|
|
|
|
N05AB
|
|
Phenothiazines with piperazine structure
|
|
|
|
N05AC
|
|
Phenothiazines with piperidine structure
|
|
|
|
N05AD
|
|
Butyrophenone derivatives
|
|
|
|
N05AE
|
|
Indole derivatives
|
|
|
|
N05AF
|
|
Thioxanthene derivative
|
|
|
|
N05AG
|
|
Diphenylbutylpiperidine derivatives
|
|
|
|
N05AH
|
|
Diazepines, oxazepines, thiazepines and oxepines
|
|
|
|
N05AL
|
|
Benzamides
|
|
|
|
N05AN
|
|
Lithium
|
|
|
|
N05AX
|
|
Other antipsychotics
|
|
|
|
|
N05AX07
|
Prothipendyl
|
|
|
|
|
N05AX08
|
Risperidone
|
|
|
|
|
N05AX10
|
Mosapramine
|
|
|
|
|
N05AX11
|
Zotepine
|
|
|
|
|
N05AX12
|
Aripiprazole
|
|
|
|
|
N05AX13
|
Paliperidone
|
|
|
|
|
N05AX14
|
Iloperidone
|
|
|
N05B
|
|
|
Anxiolytics
|
|
|
N05C
|
|
|
Hypnotics and sedatives
|
|
N06
|
|
|
|
Psychoanaleptics
|
|
N07
|
|
|
|
Other nervous system drugs
|
P
|
|
|
|
|
Antiparasitic products, insecticides and repellents
|
|
P01
|
|
|
|
Antiprotozoals
|
|
P02
|
|
|
|
Anthelmintics
|
|
P03
|
|
|
|
Ectoparasiticides, including scabicides, insecticides and repellents
|
R
|
|
|
|
|
Respiratory system
|
|
R01
|
|
|
|
Nasal preparations
|
|
R02
|
|
|
|
Throat preparations
|
|
R03
|
|
|
|
Drugs for obstructive airway diseases
|
|
R05
|
|
|
|
Cough and cold preparations
|
|
R06
|
|
|
|
Antihistamines for systemic use
|
|
R07
|
|
|
|
Other respiratory system products
|
S
|
|
|
|
|
Sensory organs
|
|
S01
|
|
|
|
Ophthalmologicals
|
|
S02
|
|
|
|
Otologicals
|
|
S03
|
|
|
|
Ophthalmological and otological preparations
|
V
|
|
|
|
|
Various
|
|
V01
|
|
|
|
Allergens
|
|
V03
|
|
|
|
All other therapeutic products
|
|
V04
|
|
|
|
Diagnostic agents
|
|
V06
|
|
|
|
General nutrients
|
|
V07
|
|
|
|
All other non-therapeutic products
|
|
V08
|
|
|
|
Contrast media
|
|
V09
|
|
|
|
Diagnostic radiopharmaceuticals
|
|
V10
|
|
|
|
Therapeutic radiopharmaceuticals
|
|
V20
|
|
|
|
Surgical dressings
|